177 related articles for article (PubMed ID: 17154501)
1. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.
Kopka K; Faust A; Keul P; Wagner S; Breyholz HJ; Höltke C; Schober O; Schäfers M; Levkau B
J Med Chem; 2006 Nov; 49(23):6704-15. PubMed ID: 17154501
[TBL] [Abstract][Full Text] [Related]
2. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.
Faust A; Wagner S; Law MP; Hermann S; Schnöckel U; Keul P; Schober O; Schäfers M; Levkau B; Kopka K
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):67-73. PubMed ID: 17372575
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.
Podichetty AK; Wagner S; Schröer S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
J Med Chem; 2009 Jun; 52(11):3484-95. PubMed ID: 19445513
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
[TBL] [Abstract][Full Text] [Related]
5. Influence of 4- or 5-substituents on the pyrrolidine ring of 5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin derivatives on their inhibitory activities towards caspases-3 and -7.
Limpachayaporn P; Riemann B; Kopka K; Schober O; Schäfers M; Haufe G
Eur J Med Chem; 2013 Jun; 64():562-78. PubMed ID: 23685941
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new fluorinated, 2-substituted 5-pyrrolidinylsulfonyl isatin derivatives as caspase-3 and caspase-7 inhibitors: nonradioactive counterparts of putative PET-compatible apoptosis imaging agents.
Limpachayaporn P; Schäfers M; Schober O; Kopka K; Haufe G
Bioorg Med Chem; 2013 Apr; 21(7):2025-36. PubMed ID: 23411396
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors.
Podichetty AK; Wagner S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
Future Med Chem; 2009 Aug; 1(5):969-89. PubMed ID: 21426092
[TBL] [Abstract][Full Text] [Related]
8. N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.
Chu W; Zhang J; Zeng C; Rothfuss J; Tu Z; Chu Y; Reichert DE; Welch MJ; Mach RH
J Med Chem; 2005 Dec; 48(24):7637-47. PubMed ID: 16302804
[TBL] [Abstract][Full Text] [Related]
9. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.
Chu W; Rothfuss J; d'Avignon A; Zeng C; Zhou D; Hotchkiss RS; Mach RH
J Med Chem; 2007 Jul; 50(15):3751-5. PubMed ID: 17585855
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 7-halogenated isatin sulfonamides: nonradioactive counterparts of caspase-3/-7 inhibitor-based potential radiopharmaceuticals for molecular imaging of apoptosis.
Limpachayaporn P; Wagner S; Kopka K; Schober O; Schäfers M; Haufe G
J Med Chem; 2014 Nov; 57(22):9383-95. PubMed ID: 25358116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.
Zhou D; Chu W; Rothfuss J; Zeng C; Xu J; Jones L; Welch MJ; Mach RH
Bioorg Med Chem Lett; 2006 Oct; 16(19):5041-6. PubMed ID: 16891117
[TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxicity evaluation of some substituted isatin derivatives.
Vine KL; Locke JM; Ranson M; Benkendorff K; Pyne SG; Bremner JB
Bioorg Med Chem; 2007 Jan; 15(2):931-8. PubMed ID: 17088067
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, 18F-radiolabeling, and in vivo biodistribution studies of N-fluorohydroxybutyl isatin sulfonamides using positron emission tomography.
Limpachayaporn P; Wagner S; Kopka K; Hermann S; Schäfers M; Haufe G
J Med Chem; 2013 Jun; 56(11):4509-20. PubMed ID: 23656488
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.
Vine KL; Locke JM; Ranson M; Pyne SG; Bremner JB
J Med Chem; 2007 Oct; 50(21):5109-17. PubMed ID: 17887662
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6.
Chu W; Rothfuss J; Chu Y; Zhou D; Mach RH
J Med Chem; 2009 Apr; 52(8):2188-91. PubMed ID: 19326941
[TBL] [Abstract][Full Text] [Related]
16. Novel fluorine-18 labeled 5-(1-pyrrolidinylsulfonyl)-7-azaisatin derivatives as potential PET tracers for in vivo imaging of activated caspases in apoptosis.
Waldmann CM; Hermann S; Faust A; Riemann B; Schober O; Schäfers M; Haufe G; Kopka K
Bioorg Med Chem; 2015 Sep; 23(17):5734-9. PubMed ID: 26210158
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.
Aulabaugh A; Kapoor B; Huang X; Dollings P; Hum WT; Banker A; Wood A; Ellestad G
Biochemistry; 2007 Aug; 46(33):9462-71. PubMed ID: 17649976
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
Hyatt JL; Moak T; Hatfield MJ; Tsurkan L; Edwards CC; Wierdl M; Danks MK; Wadkins RM; Potter PM
J Med Chem; 2007 Apr; 50(8):1876-85. PubMed ID: 17378546
[TBL] [Abstract][Full Text] [Related]
19. A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.
Chapman JG; Magee WP; Stukenbrok HA; Beckius GE; Milici AJ; Tracey WR
Eur J Pharmacol; 2002 Dec; 456(1-3):59-68. PubMed ID: 12450570
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
